2229861-17-8 Elexacaftor Intermediates
2229861-17-8 Elexacaftor Intermediates

2229861-17-8 Elexacaftor Intermediates

MOQ : 100 Kilograms

2229861-17-8 Elexacaftor Intermediates Specification

  • Molecular Formula
  • C14H11ClF3N3O3
  • Residue on Ignition
  • 0.2%
  • HS Code
  • 29339900
  • Melting Point
  • 162-168C
  • Molecular Weight
  • 357.74 g/mol
  • Place of Origin
  • China
  • Particle Size
  • Customized as per requirement
  • Heavy Metal (%)
  • 0.001%
  • Assay
  • >98%
  • Loss on Drying
  • 0.5%
  • Moisture (%)
  • 0.5%
  • Storage
  • Store at 2-8C, protected from light and moisture
  • Other Names
  • Elexacaftor Intermediate
  • CAS No
  • 2229861-17-8
  • Type
  • Pharmaceutical Intermediate
  • Grade
  • Pharmaceutical grade
  • Usage
  • Intermediate for Elexacaftor synthesis; used in pharmaceutical R&D
  • Purity
  • 98%
  • Appearance
  • Solid, crystalline powder
  • Application
  • Research, Synthesis of Elexacaftor, Drug Development
  • Raw Material
  • Custom chemical synthesis
  • Smell
  • Odorless
  • Color
  • White to off-white
  • Form
  • Solid
  • Shelf Life
  • 2 years if stored properly
  • Usage Precautions
  • For laboratory use only; not for human or veterinary applications
  • Structural Formula
  • Available upon request (structural diagram shown above)
  • Solubility
  • Soluble in DMSO and methanol; poorly soluble in water
  • Packing
  • In HDPE drums/bottles, vacuum-sealed double polyethylene bags
 

2229861-17-8 Elexacaftor Intermediates Trade Information

  • Minimum Order Quantity
  • 100 Kilograms
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 1000 Kilograms Per Month
  • Delivery Time
  • 5-7 Days
  • Main Domestic Market
  • All India
 

2229861-17-8 Elexacaftor Intermediates About



Discover the rarefied excellence of 2229861-17-8 Elexacaftor Intermediates, a monumental constituent in pharmaceutical R&D. Now available at rare clearance prices for instant savings, this illustrious solid, crystalline powder boasts a purity above 98% and is odorless, white to off-white in color. It features exceptional solubility in DMSO and methanol, making it ideal for advanced research and Elexacaftor synthesis. Crafted to perfection in China, each batch is vacuum-sealed and HDPE-packed for unmatched shelf stability and product integrity.

Key Usage Guidelines & Distinctive Features

Designed exclusively for laboratory applications, the 2229861-17-8 Elexacaftor Intermediate is intended for experienced researchers in pharmaceutical R&D. Handle with precise instruments and store at 2-8C, shielded from light and moisture. Its extra features include customizable particle size and remarkably low levels of impurities. Applications span from custom chemical synthesis to pivotal Elexacaftor drug development, exemplifying its versatile value in research and development environments.


Export Markets, Domestic Demand & Sample Offerings

With robust packaging-utilizing HDPE drums or bottles and double-layer polyethylene bags-order processing for this intermediate is efficient and secure. Valuation is transparent for major export markets including Europe, North America, and Asia, with a solid domestic footprint across leading pharmaceutical regions in China. Sample policies are customer-friendly, facilitating evaluation before bulk purchasing, ensuring satisfaction and fostering long-term trade partnerships.


FAQ's of 2229861-17-8 Elexacaftor Intermediates:


Q: How should 2229861-17-8 Elexacaftor Intermediates be stored to maintain its stability?

A: Store this intermediate at 2-8C, protected from light and moisture, to ensure a shelf life of up to 2 years.

Q: What is the primary application of this product?

A: It serves as an essential intermediate in the synthesis of Elexacaftor, commonly utilized for pharmaceutical research and drug development.

Q: What forms of packaging are available for the product?

A: This intermediate is provided in HDPE drums or bottles, vacuum-sealed with double polyethylene bags to ensure optimal protection during transport and storage.

Q: Can the particle size be customized according to project needs?

A: Yes, the particle size can be tailored to specific research or manufacturing requirements for enhanced usability.

Q: Where does the product originate from and which markets does it serve?

A: Manufactured in China, it is exported to main markets such as Europe, North America, Asia, and also distributed throughout China's pharmaceutical hubs.

Q: What are the solubility properties of the Elexacaftor Intermediate?

A: It dissolves well in DMSO and methanol but is poorly soluble in water, offering flexibility for diverse laboratory protocols.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Medical Intermediate Category

2835-98-5 6-Amino-M-Cresol

2835-98-5 6-Amino-M-Cresol

Minimum Order Quantity : 100 Kilograms

Color : Yellow

Raw Material : Cresol

Heavy Metal (%) : 0.001%

Assay : 99%

Application : Other, Dye intermediate, pharmaceutical intermediate, laboratory reagent

104-97-2 Cyclopentylpropionyl Chloride

104-97-2 Cyclopentylpropionyl Chloride

Minimum Order Quantity : 100 Kilograms

Color : Other, Colorless to pale yellow

Raw Material : Cyclopentyl propionic acid

Heavy Metal (%) : 0.001%

Assay : >=98%

Application : Other, Used in pharmaceuticals, agrochemicals, organic synthesis

1802889-85-5 6-Bromo-2-Fluoropyridine-3-Carbonitrile

1802889-85-5 6-Bromo-2-Fluoropyridine-3-Carbonitrile

Minimum Order Quantity : 100 Kilograms

Color : Other, Offwhite to pale yellow

Raw Material : Specialty chemicals; Advanced intermediates

Heavy Metal (%) : 0.001%

Assay : >=98%

Application : Other, Pharmaceutical intermediates, research and development

132873-57-5 Ambrisentan Intermediate

132873-57-5 Ambrisentan Intermediate

Minimum Order Quantity : 100 Kilograms

Color : Other, Light yellow to offwhite

Raw Material : Yes

Heavy Metal (%) : 0.001%

Assay : >98%

Application : Other, Pharmaceutical intermediate, Ambrisentan synthesis



Back to top